Potential physiological effects of pharmaceutical compounds in Atlantic salmon (Salmo salar) implied by transcriptomic analysis

  • Miriam Hampel
  • Esteban Alonso
  • Irene Aparicio
  • James E. Bron
  • Juan Luis Santos
  • John B. Taggart
  • Michael J. Leaver
Research Article


Background, aim, and scope

Pharmaceuticals are emerging pollutants widely used in everyday urban activities which can be detected in surface, ground, and drinking waters. Their presence is derived from consumption of medicines, disposal of expired medications, release of treated and untreated urban effluents, and from the pharmaceutical industry. Their growing use has become an alarming environmental problem which potentially will become dangerous in the future. However, there is still a lack of knowledge about long-term effects in non-target organisms as well as for human health. Toxicity testing has indicated a relatively low acute toxicity to fish species, but no information is available on possible sublethal effects. This study provides data on the physiological pathways involved in the exposure of Atlantic salmon as representative test species to three pharmaceutical compounds found in ground, surface, and drinking waters based on the evaluation of the xenobiotic-induced impairment resulting in the activation and silencing of specific genes.

Materials and methods

Individuals of Atlantic salmon (Salmo salar) parr were exposed during 5 days to environmentally relevant concentrations of three representative pharmaceutical compounds with high consumption rates: the analgesic acetaminophen (54.77 ± 34.67 µg L−1), the anticonvulsant carbamazepine (7.85 ± 0.13 µg L−1), and the beta-blocker atenolol (11.08 ± 7.98 µg L−1). Five immature males were selected for transcriptome analysis in brain tissues by means of a 17k salmon cDNA microarray. For this purpose, mRNA was isolated and reverse-transcribed into cDNA which was labeled with fluorescent dyes and hybridized against a common pool to the arrays. Lists of significantly up- and down-regulated candidate genes were submitted to KEGG (Kyoto Encyclopedia of Genes and Genomes) in order to analyze for induced pathways and to evaluate the usefulness of this method in cases of not completely annotated test organisms.


Exposure during 5 days to environmentally relevant concentrations of the selected pharmaceutical compounds acetaminophen, carbamazepine, and atenolol produced differences in the expression of 659, 700, and 480 candidate genes, respectively. KEGG annotation numbers (KO annotations) were obtained for between 26.57% and 33.33% of these differently expressed genes per treatment in comparison to non-exposure conditions. Pathways that showed to be induced did not always follow previously reported targets or metabolic routes for the employed treatments; however, several other pathways have been found (four or more features) to be significantly induced.


Energy-related pathways have been altered under exposure in all the selected treatments, indicating a possible energy budget leakage due to additional processes resulting from the exposure to environmental contaminants. Observed induction of pathways may indicate additional processes involved in the mode of action of the selected pharmaceuticals which may not have been detected with conventional methods like quantitative PCR in which only suspected features are analyzed punctually for effects. The employment of novel high-throughput screening techniques in combination with global pathway analysis methods, even if the organism is not completely annotated, allows the examination of a much broader range of candidates for potential effects of exposure at the gene level.


The continuously growing number of annotations of representative species relevant for environmental quality testing is facilitating pathway analysis processes for not completely annotated organisms. KEGG has shown to be a useful tool for the analysis of induced pathways from data generated by microarray techniques with the selected pharmaceutical contaminants acetaminophen, carbamazepine, and atenolol, but further studies have to be carried out in order to determine if a similar expression pattern in terms of fold change quantity and pathways is observed after long-term exposure. Together with the information obtained in this study, it will then be possible to evaluate the potential risk that the continuous release of these compounds may have on the environment and ecosystem functioning.


Acetaminophen Atenolol Atlantic salmon Carbamazepine cDNA microarray KEGG pathway analysis Pharmaceuticals Sublethal effects Transcriptomics 



Miriam Hampel was funded in the framework of the FP6 Marie Curie Action: Intra European Fellowships (MEIF-CT-2006-39691, acronym SALMONPHARM).


  1. Agon P, Goethals P, Van Haver D, Kaufman JM (1991) Permeability of the blood–brain barrier for atenolol studied by positron emission tomography. J Pharm Pharmacol 43(8):597–600Google Scholar
  2. Ahlborn GJ, Nelson GM, Ward WO, Knapp G, Allen JW, Ouyang M, Roop BC, Chen Y, O'Brien T, Kitchin KT, Delker DA (2008) Dose response evaluation of gene expression profiles in the skin of K6/ODC mice exposed to sodium arsenite. Toxicol Appl Pharmacol 227:400–416Google Scholar
  3. Barthel A, Schmoll D, Kruger KD, Bahrenberg G, Walther R, Roth RA, Joost HG (2001) Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. Biochem Biophys Res Commun 285:897–902CrossRefGoogle Scholar
  4. Boelsterli UA (1993) Specific targets of covalent drug–protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury. Drug Metab Rev 25:395–451CrossRefGoogle Scholar
  5. Brooks BW, Foran CM, Richards SM, Weston JJ, Turner PK, Stanley JK, Solomon KR, Slattery M, LaPoint TW (2003a) Aquatic ecotoxicology of luoxetine. Toxicol Lett 142:169–183CrossRefGoogle Scholar
  6. Brooks BW, Turner PK, Stanley JK, Weston JJ, Glidewell EA, Foran CM, Slattery M, LaPoint TW, Huggett DB (2003b) Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere 52:135–142CrossRefGoogle Scholar
  7. Burgess S, He T, Yan Z, Lindner J, Sherry A, Malloy C, Browning J, Magnuson M (2007) Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metabolism 5(4):313–320CrossRefGoogle Scholar
  8. Buser H-R, Mullere MD, Theobald N (1998) Occurrence of the pharmaceutical clofibric acid and the herbicide mecoprop in various Swiss Lakes and in the North Sea. Environ Sci Technol 32:188–192CrossRefGoogle Scholar
  9. Chen WYJ, Abantangelo G (1999) Functions of hyaluronan in wound repair. Wound Repair Regen 7(2):79–89CrossRefGoogle Scholar
  10. Cummings AJ, King ML, Martin BK (1967) A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol 29:150–157Google Scholar
  11. ECETOC Workshop Report No. 11 (2007) Workshop on the application of ‘Omic’ technologies in toxicology and ecotoxicology: case studies and risk assessment 6–7 December 2007, Malaga. European Centre for Ecotoxicology and Toxicology of ChemicalsGoogle Scholar
  12. Hoivik DJ, Fisher RL, Brendel K, Gandolfi AJ, Khairallahea CSD (1996) Protein arylation precedes acetaminophen toxicity in a dynamic organ slice culture of mouse kidney. Fundam Appl Toxicol 34:99–104CrossRefGoogle Scholar
  13. Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB (1973) Acetaminophen-induced hepatic necrosis: II Role of covalent binding in vivo. J Pharmacol Exp Ther 187:195–202Google Scholar
  14. Kanehisa M, Goto S, Kawashima S, Nakaya A (2002) The KEGG databases at Genome Net. Nucleic Acids Res 30(1):42–46CrossRefGoogle Scholar
  15. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res, 36, database issue D480–D484 (doi:10.1093/nar/gkm882).
  16. Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, Konishi H, Matsuzaki H, Kikkawa U, Ogawa W, Kasuga M (1999) Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 19:6286–6296Google Scholar
  17. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211CrossRefGoogle Scholar
  18. Kümmerer K (2001) Pharmaceuticals in the environment: emission of pharmaceuticals, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources—a review. Chemosphere 45:957–969CrossRefGoogle Scholar
  19. Nelson SD, Pearson PG (1990) Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu Rev Pharmacol Toxicol 30:169–195CrossRefGoogle Scholar
  20. OECD Guideline for Testing of Chemicals 203: Fish, Acute Toxicity Test (Updated Guideline, adopted 17th July 1992) and 204 Fish, Prolonged Toxicity Test: 14-Day Study (Original Guideline, adopted 4th April 1984)Google Scholar
  21. Ogawa W, Matozaki T, Kasuga M (1998) Role of binding proteins to IRS-1 in insulin signalling. Mol Cell Biochem 182:13–22CrossRefGoogle Scholar
  22. Pancholi V (2001) Multifunctional a-enolase: its role in diseases. Cell Mol Life Sci 58:902–920CrossRefGoogle Scholar
  23. Potter WZ, Thorgeirsson SS, Jollow DJ, Mitchell JR (1974) Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology 12:129–143CrossRefGoogle Scholar
  24. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806CrossRefGoogle Scholar
  25. Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR (2004) Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regulat Toxicol Pharmacol 39:158–183CrossRefGoogle Scholar
  26. Santos JL, Aparicio I, Alonso E, Callejón M (2005) Simultaneous determination of pharmaceutically active compounds in wastewater samples by solid phase extraction and high-performance liquid chromatography with diode array and fluorescence detectors. Anal Chim Acta 550:116–122CrossRefGoogle Scholar
  27. Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R, Unterman TG (2000) Regulation of glucose-6-phosphatase gene expression by protein kinase B alpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent effects of insulin on promotor activity. J Biol Chem 275:36324–36333CrossRefGoogle Scholar
  28. Taggart JB, Bron JE, Martin SAM, Seear PJ, Høyheim B, Talbot R, Carmichael SN, Villeneuve LAN, Sweeney GE, Houlihan DF, Secombes CJ, Tocher DR, Teale AJ (2008) A description of the origins, design and performance of the TRAITS–SGP Atlantic salmon Salmo salar L. cDNA microarray. J Fish Biol 72:2071–2094CrossRefGoogle Scholar
  29. Tarze A, Deniaud A, Le Bras M, Maillier E, Molle D, Larochette N, Zamzami N, Jan G, Kroemer G, Brenner C (2007) GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 26:2606–2620CrossRefGoogle Scholar
  30. Ternes TA, Stumpf M, Mueller J, Haberer K, Wilken R-D, Servos M (1999) Behavior and occurrence of estrogens in municipal sewage treatment plants—I. investigations in Germany, Canada and Brazil. Sci Total Environ 225:81–90CrossRefGoogle Scholar
  31. Ternes TA (1998) Occurrence of pharmaceuticals in German sewage treatment plants and rivers. Water Res 32:3245–3260CrossRefGoogle Scholar
  32. Turley EA, Austen L, Vandeligt K, Clary C (1991) Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol March 112(5):1041–1047CrossRefGoogle Scholar
  33. Vermeulen NPE, Bessems JGM, Van De Straat R (1992) Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metab Rev 24:367–407CrossRefGoogle Scholar
  34. Yin Y, Yuan H, Wang C, Pattabiraman N, Rao M, Pestell RG, Glazer RI (2005) 3-Phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor and promotes adipocyte differentiation. Mol Endocrinol 20(2):268–278CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Miriam Hampel
    • 1
  • Esteban Alonso
    • 2
  • Irene Aparicio
    • 2
  • James E. Bron
    • 1
  • Juan Luis Santos
    • 2
  • John B. Taggart
    • 1
  • Michael J. Leaver
    • 1
  1. 1.Institute of AquacultureUniversity of StirlingStirlingUK
  2. 2.Universidad de SevillaSevillaSpain

Personalised recommendations